Curcumin-cyclodextrin encapsulated chitosan nanoconjugates with enhanced solubility and cell cytotoxicity

Colloids and Surfaces B: Biointerfaces

Volumn 117, Issue , 2014, Pages 520-527

  Popat, Amirali ^a   Karmakar, Surajit ^a   Jambhrunkar, Siddharth ^a   Xu, Chun ^a   Yu, Chengzhong ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cellular delivery; Chitosan; Curcumin; Cyclodextrin; Spray drying

Indexed keywords

BIOLOGICAL MATERIALS; CATALYST ACTIVITY; CELL CULTURE; CELL DEATH; CHITOSAN; CYCLODEXTRINS; CYTOTOXICITY; DISEASES; DRUG DELIVERY; GENE TRANSFER; SOLUBILITY; SPRAY DRYING;

APOPTOTIC CELL DEATH; CELL CYCLE ANALYSIS; CELLULAR DELIVERY; CURCUMIN; HYDROPHOBIC DRUG DELIVERY; HYDROXYPROPYL CYCLODEXTRINS; NATURAL BIOMATERIALS; SPRAY-DRYING METHOD;

NANOPARTICLES;

CHITOSAN; CURCUMIN; CYCLODEXTRIN; GAMMA HYDROXYPROPYL CYCLODEXTRIN; UNCLASSIFIED DRUG; CARBOCYANINE; CYANINE DYE 3; GAMMA CYCLODEXTRIN DERIVATIVE; HYDROXYPROPYL-GAMMA-CYCLODEXTRIN; NANOCONJUGATE;

APOPTOSIS; ARTICLE; CELL CYCLE ASSAY; CELL MEDIATED CYTOTOXICITY; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; NANOENCAPSULATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFECTS; LIGHT; METABOLISM; RADIATION SCATTERING; SOLUBILITY; TUMOR CELL LINE; ULTRASTRUCTURE;

CALORIMETRY, DIFFERENTIAL SCANNING; CARBOCYANINES; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; CURCUMIN; GAMMA-CYCLODEXTRINS; HUMANS; LIGHT; NANOCONJUGATES; SCATTERING, RADIATION; SOLUBILITY;

EID: 84899657341     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.03.005     Document Type: Article

References (32)

1. Yallapu M.M., Jaggi M., Chauhan S.C. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov. Today 2012, 17:71-80.
2. Caesar I., Jonson M., Nilsson K.P.R., Thor S., Hammarström P. Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila. PLoS ONE 2012, 7:e31424.
3. Wilken R., Veena M., Wang M., Srivatsan E. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 2011, 10:12.
4. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
5. Yallapu M., Maher D., Sundram V., Bell M., Jaggi M., Chauhan S. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J. Ovarian Res. 2010, 3:11.
6. ®) in cancer patients. Cancer Chemother. Pharmacol. 2013, 71:1521-1530.
7. Yadav V.R., Prasad S., Kannappan R., Ravindran J., Chaturvedi M.M., Vaahtera L., Parkkinen J., Aggarwal B.B. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem. Pharmacol. 2010, 80:1021-1032.
8. Yadav V.R., Suresh S., Devi K., Yadav S. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech 2009, 10:752-762.
9. Clifford N.W., Iyer K.S., Raston C.L. Encapsulation and controlled release of nutraceuticals using mesoporous silica capsules. J. Mater. Chem. 2008, 18:162-165.
10. ® HS15 as a carrier. Int. J. Pharm. 2012, 424:18-25.
11. Dhule S.S., Penfornis P., Frazier T., Walker R., Feldman J., Tan G., He J., Alb A., John V., Pochampally R. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomed. Nanotech. Biol. Med. 2012, 8:440-451.
12. Mulik R.S., Mönkkönen J., Juvonen R.O., Mahadik K.R., Paradkar A.R. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int. J. Pharm. 2010, 398:190-203.
13. Trapani A., Lopedota A., Franco M., Cioffi N., Ieva E., Garcia-Fuentes M., Alonso M.J. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Eur. J. Pharm. Biopharm. 2010, 75:26-32.
14. Colletier J.P., Chaize B., Winterhalter M., Fournier D. Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer. BMC Biotechnol. 2002, 2:9.
15. Peniche H., Peniche C. Chitosan nanoparticles: a contribution to nanomedicine. Polym. Int. 2011, 60:883-889.
16. Bernkop-Schnürch A., Dünnhaupt S. Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm. 2012, 81:463-469.
17. Jean M., Alameh M., De Jesus D., Thibault M., Lavertu M., Darras V., Nelea M., Buschmann M.D., Merzouki A. Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes. Eur. J. Pharm. Sci. 2012, 45:138-149.
18. Lee J., Yun K.-S., Choi C.S., Shin S.-H., Ban H.-S., Rhim T., Lee S.K., Lee K.Y. T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles. Bioconjug. Chem. 2012, 23:1174-1180.
19. Lee S.J., Huh M.S., Lee S.Y., Min S., Lee S., Koo H., Chu J.-U., Lee K.E., Jeon H., Choi Y., Choi K., Byun Y., Jeong S.Y., Park K., Kim K., Kwon I.C. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment. Angew. Chem. Int. Ed. 2012, 51:7203-7207.
20. Mazzarino L., Travelet C., Ortega-Murillo S., Otsuka I., Pignot-Paintrand I., Lemos-Senna E., Borsali R. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J. Colloid Interface Sci. 2012, 370:58-66.
21. Anitha A., Deepagan V.G., Divya Rani V.V., Menon D., Nair S.V., Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles. Carbohydr. Polym. 2011, 84:1158-1164.
22. Denadai A.M., De Sousa F.B., Passos J.J., Guatimosim F.C., Barbosa K.D., Burgos A.E., de Oliveira F.C., da Silva J.C., Neves B.R., Mohallem N.D., Sinisterra R.D. Self-assembled organic-inorganic magnetic hybrid adsorbent ferrite based on cyclodextrin nanoparticles. Beilstein J. Org. Chem. 2012, 8:1867-1876.
23. Yallapu M.M., Jaggi M., Chauhan S.C. β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf. B 2010, 79:113-125.
24. Aljaberi A., Chatterji A., Dong Z., Shah N.H., Malick W., Singhal D., Sandhu H.K. Understanding and optimizing the dual excipient functionality of sodium lauryl sulfate in tablet formulation of poorly water soluble drug: wetting and lubrication. Pharm. Dev. Technol. 2013, 18:490-503.
25. Suwannateep N., Banlunara W., Wanichwecharungruang S.P., Chiablaem K., Lirdprapamongkol K., Svasti J. Mucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulation. J. Control. Release 2011, 151:176-182.
26. Calvo P., Remuñán-López C., Vila-Jato J.L., Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 1997, 63:125-132.
27. Maestrelli F., Garcia-Fuentes M., Mura P., Alonso M.J. A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin. Eur. J. Pharm. Biopharm. 2006, 63:79-86.
28. Yuan Z., Ye Y., Gao F., Yuan H., Lan M., Lou K., Wang W. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. Int. J. Pharm. 2013, 446:191-198.
29. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., Maitra A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J. Nanobiotechnol. 2007, 5:1-18.
30. Ranjan A.P., Mukerjee A., Helson L., Vishwanatha J.K. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J. Nanobiotechnol. 2012, 10:1-18.
31. Malmo J., Sørgård H., Vårum K.M., Strand S.P. siRNA delivery with chitosan nanoparticles: molecular properties favoring efficient gene silencing. J. Control. Release 2012, 158:261-268.
32. Liu E., Wu J., Cao W., Zhang J., Liu W., Jiang X., Zhang X. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J. Neurooncol. 2007, 85:263-270.